Laurence Clément

1.6k total citations
34 papers, 432 citations indexed

About

Laurence Clément is a scholar working on Hematology, Epidemiology and Oncology. According to data from OpenAlex, Laurence Clément has authored 34 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 10 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Laurence Clément's work include Hematopoietic Stem Cell Transplantation (13 papers), Acute Myeloid Leukemia Research (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). Laurence Clément is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Acute Myeloid Leukemia Research (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). Laurence Clément collaborates with scholars based in France, United States and Netherlands. Laurence Clément's co-authors include Pierre Bordigoni, Alexandra Salmon, Cédric Baumann, L. Mainard, Véronique Venard, Sophie Dimicoli, Hélène Jeulin, Francis Witz, Pierre Feugier and Nelly Agrinier and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and European Journal of Pharmacology.

In The Last Decade

Laurence Clément

31 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laurence Clément France	13	167	128	127	120	60	34	432
Gergely Kriván Hungary	12	157 0.9×	114 0.9×	114 0.9×	158 1.3×	20 0.3×	58	449
Makito Tanaka Japan	15	244 1.5×	166 1.3×	89 0.7×	202 1.7×	83 1.4×	44	588
Aude Marie‐Cardine France	9	137 0.8×	73 0.6×	56 0.4×	112 0.9×	34 0.6×	24	414
W Rybka United States	9	318 1.9×	158 1.2×	112 0.9×	93 0.8×	50 0.8×	14	489
T. Fukuda Japan	14	128 0.8×	84 0.7×	151 1.2×	80 0.7×	101 1.7×	34	534
R Destro Italy	10	223 1.3×	64 0.5×	57 0.4×	87 0.7×	51 0.8×	19	419
Hakan Koç Türkiye	10	216 1.3×	96 0.8×	75 0.6×	66 0.6×	19 0.3×	38	369
Masahiro Yasui Japan	12	86 0.5×	145 1.1×	47 0.4×	122 1.0×	56 0.9×	40	404
Emma Watz Sweden	14	369 2.2×	234 1.8×	119 0.9×	288 2.4×	29 0.5×	25	640
Sinem Civriz Bozdağ Türkiye	10	214 1.3×	114 0.9×	52 0.4×	71 0.6×	27 0.5×	61	397

Countries citing papers authored by Laurence Clément

Since Specialization

Citations

This map shows the geographic impact of Laurence Clément's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Clément with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Clément more than expected).

Fields of papers citing papers by Laurence Clément

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Clément. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Clément. The network helps show where Laurence Clément may publish in the future.

Co-authorship network of co-authors of Laurence Clément

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Clément. A scholar is included among the top collaborators of Laurence Clément based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Clément. Laurence Clément is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cazaubiel, Titouan, Édouard Forcade, Audrey Bidet, et al.. (2025). Relapsed Philadelphia chromosome‐positive B‐cell acute lymphoblastic leukaemia responds well to a combination of modified hyper‐CVAD, blinatumomab and tyrosine kinase inhibitor. eJHaem. 6(1). e1064–e1064.

Rialland, Fanny, Audrey Grain, Myriam Labopin, et al.. (2022). Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trial. Bone Marrow Transplantation. 57(11). 1698–1703.

Sheth, Vipul, Fernanda Volt, Jaime Sanz, et al.. (2020). Reduced-Intensity versus Myeloablative Conditioning in Cord Blood Transplantation for Acute Myeloid Leukemia (40-60 years) across Highly Mismatched HLA Barriers—On Behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT. Biology of Blood and Marrow Transplantation. 26(11). 2098–2104. 4 indexed citations

Cazaubiel, Titouan, Édouard Forcade, Thibaut Leguay, et al.. (2017). Severe acute GvHD following administration of ipilimumab for early relapse of AML after haploidentical stem cell transplantation. Bone Marrow Transplantation. 52(7). 1047–1048. 8 indexed citations

Pochon, Cécile, Loïc Reppel, Pierre Hallé, et al.. (2016). Cryopreservation as a way to maintain extracorporeal photopheresis regimen for GvHD treatment while circumventing patient temporary inability to undergo apheresis. Bone Marrow Transplantation. 52(1). 167–170. 6 indexed citations

Malard, Florent, Nöel Milpied, Didier Blaise, et al.. (2015). Effect of Graft Source on Unrelated Donor Hemopoietic Stem Cell Transplantation in Adults with Acute Myeloid Leukemia after Reduced-Intensity or Nonmyeloablative Conditioning: A Study from the Société Francaise de Greffe de Moelle et de Thérapie Cellulaire. Biology of Blood and Marrow Transplantation. 21(6). 1059–1067. 16 indexed citations

Qian, Chongsheng, Yingying Wang, Huili Cai, et al.. (2015). Adenovirus-specific T-cell Subsets in Human Peripheral Blood and After IFN-γ Immunomagnetic Selection. Journal of Immunotherapy. 39(1). 27–35. 8 indexed citations

Wang, Yingying, J.-M. Virion, Manoel de Carvalho, et al.. (2013). Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy. Cytotherapy. 16(1). 122–134. 7 indexed citations

Jeulin, Hélène, Nelly Agrinier, Alexandra Salmon, et al.. (2013). Human Herpesvirus 6 Infection After Allogeneic Stem Cell Transplantation. Transplantation. 95(10). 1292–1298. 35 indexed citations

10.

Ghesquières, Hervé, Aspasia Stamatoullas, Olivier Casasnovas, et al.. (2013). Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patients. Leukemia & lymphoma. 54(11). 2399–2404. 21 indexed citations

11.

Lesesve, Jean‐François, François Alla, Sylvain Salignac, et al.. (2011). Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation. International Journal of Laboratory Hematology. 33(4). 343–356. 10 indexed citations

12.

Salmon, Alexandra, Anne Debourgogne, Laurence Clément, et al.. (2010). Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature. Clinical Microbiology and Infection. 16(5). 508–512. 20 indexed citations

13.

Kimmoun, Antoine, Audrey Contet, Laurence Clément, et al.. (2010). Successful management with clofarabine for refractory leukaemia in a young adult with chronic renal failure. American Journal of Hematology. 86(3). 321–323. 2 indexed citations

14.

Decot, Véronique, Véronique Venard, Hélène Jeulin, et al.. (2010). Rapid Generation of Full Clinical-Grade Human Antiadenovirus Cytotoxic T Cells for Adoptive Immunotherapy. Journal of Immunotherapy. 33(4). 414–424. 20 indexed citations

15.

Cruciani‐Guglielmacci, Céline, Nadim Kassis, Laurence Clément, et al.. (2009). S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats. European Journal of Pharmacology. 608(1-3). 104–111. 9 indexed citations

16.

Mainard, L., et al.. (2008). Focal nodular hyperplasia of the liver following hematopoietic SCT. Bone Marrow Transplantation. 43(2). 127–132. 41 indexed citations

17.

Clément, Laurence, et al.. (2007). Imagerie des formes viscérales graves de la mucormycose chez 5 patients immunodéprimés. Journal de Radiologie. 88(5). 677–683. 2 indexed citations

18.

Bordigoni, Pierre, Sophie Dimicoli, Laurence Clément, et al.. (2006). Daclizumab, an efficient treatment for steroid‐refractory acute graft‐versus‐host disease. British Journal of Haematology. 135(3). 382–385. 41 indexed citations

19.

Dimicoli, Sophie, Véronique Latger‐Cannard, J. Straczek, et al.. (2003). Complete recovery from Cryptosporidium parvum infection with gastroenteritis and sclerosing cholangitis after successful bone marrow transplantation in two brothers with X-linked hyper-IgM syndrome. Bone Marrow Transplantation. 32(7). 733–737. 23 indexed citations

20.

Hulin, C., et al.. (1999). Des leucocytes chevelus et fébriles. La Revue de Médecine Interne. 20. 313s–314s. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact